# Page 1
Tab for 2018-19 under Revised National Tuberculosis Control Programme. Administrative approval for the purchase of pyridoxine.
The Government of Maharashtra
the Department of Public Health
Government Resolution No: PRASHAMA-1018/ PR No.525/ A-7
10th Floor, Hospital Building
New Ministry, Mumbai- 400001.
The date: March 18, 2019.
Read: 1) Letter No. 5 of the Joint Director, Health Services (Leprosy and Tuberculosis), Mumbai. Sasanase/ Leprosy/ Room-Au. BHAN/ PIP 18-19/ RNTCP/ PRODUCTION/ 17473-76 dated 22nd October, 2018.
(2) The Joint Director, Health Services (Leprosy and Tuberculosis), Mumbai vide letter No. Sasanase/ Leprosy/ Room-Au. Bhan/ 18/22749, dated 07.12.2018.
INTRODUCTION: In the revised National Tuberculosis Control Programme (NTCP) for 2018-19 under National Health Mission (NHM), it has been decided to introduce Tab along with IPT to prevent adverse effects of Isoniazid. Administrative approval for the purchase of Pyridoxine 25mg was under consideration by the government.
Government's decision:
For the revised National Tuberculosis Control Programme (NTCP) under National Health Mission (NHM) during the financial year 2018-19, the total amount required for procurement of Tab Pyridoxine 25mg to be administered along with IPT to prevent side effects of Isoniazid drug under PIP is Rs. A grant of Rs. 107.00 lakh has been provided. Tab of this grant. Pyridoxine 25mg for Rs. Administrative approval is being given to process the tender of Rs. 11.20 lakh. The details of the grant and procurement are as follows:
# Page 2
Government Resolution No: PRASHAMA-1018/ PR No.525/ A-7
------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
| FMR code                                                  | Technical Specification of Tablet Pyridoxine 25 mg                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              | Approx rate In Rs. | Total required quantity | App.Total Cost In Rs. |
| (6.2.1 4.2) PIP 2018-19 Procure ment of Drugs             | Product Code 57 A. Specific requirements Item: Product Code 57 ( PC 57 ) consists of Pyridoxine (25 mg.) tablets. The drug contained in the product shall be currently registered in the country of manufacture and shall meet all requirements of the licensing authority of the country of manufacture. The drug contained in the product shall also be currently registered in India and shall meet all the requirements of the licensing authority in India. Description: Pyridoxine Tablets contained in blisters of the strip shall conform to the general requirements of Tablets and the requirements under individual monograph given in IP or other Pharmacopoeia of equivalent accuracy in case of international transactions. Pyridoxine Tablets contain Pyridoxine Hydrochloride. Each Tablet shall contain- Pyridoxine Hydrochloride IP 25 mg The quality of Pyridoxine Hydrochloride should conform to the requirements of the individual monograph given in IP or other Pharmacopoeia of equivalent accuracy in case of international transactions. B. Storage: As per applicable Pharmacopoeia. C. Shelf Life: Shelf life would be 36 months. Strip of 10 tablets. UOM of Measurement:- Tablet | 0.8                | 1400000                 | 1120000               |
| Total Amount of Rs. (Rs.Elevan lacs Twenty thousand only) | 11, 20,000                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
2. Submission in the present case by Joint Director, Health Services, (Tuberculosis and Leprosy), Pune
Tab in accordance with the above proposal. Pyridoxine 25 mg is available for Rs. 11.20
from the provisions available under the heading of FMR Code 6.2.14.2 for the purchase of the target
Administrative approval is granted subject to the following conditions:
1) The tab. Proof of need for Pyridoxine 25mg
should be done. Thereafter, the tender process will be initiated.
2) The tab. Pyridoxine 25mg specifications as required and updated
It should be verified. Technical specifications of the items to be purchased
Specification) approved by the concerned experts (Technical Committee/ Officials)
It should be according to the guidelines. In addition, the technical specifications
Page 2 of 4
# Page 3
Government Resolution No: PRASHAMA-1018/ PR No.525/ A-7
It should be ensured that it is not designed in a way that will benefit any particular company. After that, you have to buy them.
3) Government departments published under the Government Decision, Industry, Energy and Labor Department, No. 2014/ No. 82/ Part-III/ Industry-4, dated December 1, 2016
The prescribed procurement procedure should be carried out in accordance with the provisions of the revised Manual of Procedure for Office Purchases.
4) The rates of the proposed procurement are estimated at the time of granting administrative approval. The final price must be determined at the end of the purchase process. It should be ensured that the price is less than the market price and not more than the rate at which the concerned supplier has supplied these items to other places and a certificate should be obtained from the concerned.
5) Items to be procured should be pre/ post dispatch random sample inspection to ensure that the goods are purchased with proper and proper specifications.
6) Storage and distribution of the items to be purchased after supply, as well as supply chain management and inventory management should be done in a proper manner to ensure that these items do not remain unused and are used in a timely manner.
7) The expenditure for the purchase of the drug should be met from the grant sanctioned under the National Health Mission under the head of the program's FMR Code 6.2.14.2.
8) Also, the program head should ensure that the purchase of these items will not be duplicated under other schemes. If so, appropriate action will be taken against them as per law.
The Central Vigilance Commission (CVC) guidelines should be strictly followed while carrying out the entire procurement process.
30/ Part- 2/2013/ Regulations, dated 17th April, 2015 in Annexure A No. 4 to the Financial Powers Rules, 1978, Part I, Sub-Section-II, Rule No. 7 in front of No. 6 conditions must be met.
Supply orders should be issued only after the approval of the Purchasing Committee after the completion of the procurement process.
Page 3 of 4
# Page 4
Government Resolution No: PRASHAMA-1018/ PR No.525/ A-7
12) Supply orders should be issued only after the approval of the Purchasing Committee after the completion of the procurement process. In this regard, the Public Health Department, vide Government Resolution No. Procurement should be carried out in accordance with the provisions of the Government Decision of 2016/ EC 240/ Health-8 dated July 26, 2017.
The Commissioner (Health Services) and the Mission Director, National Health Mission, Mumbai and the Director, Directorate of Health Services, Mumbai and the Programme Heads implementing the above programmes shall be solely responsible for ensuring that the procurement is as per the norms and requirements.
This Government Resolution, Department of Finance, vide No. 2013/ P.S. 30/13/ Regulations, Part-II, dated 17th April, 2015, in the Financial Powers Rules, 1978, Part-I, Sub-Section-II, Section 4, Rule No. The said Government Decision is being issued in accordance with the powers conferred on the Administrative Department to approve the purchase of implements, retail equipment and activity kits under Section 7.